Agathe Edet-Sanson
Overview
Explore the profile of Agathe Edet-Sanson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ciappuccini R, Nascimento C, Edet-Sanson A, Bardet S
Bull Cancer
. 2024 Nov;
111(10S1):10S64-10S72.
PMID: 39505438
NUCLEAR MEDICINE AND THYROID CANCERS IN 2024: IODINE 131, PET AND NEW THERANOSTIC APPROACHES: Nuclear medicine has long been a mainstay in the management of thyroid cancers. In patients with...
2.
Tonnelet D, Edet-Sanson A, Augusto L, Cabourg M, Thureau S
Clin Nucl Med
. 2024 Oct;
49(12):e668-e669.
PMID: 39466634
Patients with metastatic castration-resistant prostate cancer usually have lymph nodes and bone metastasis. We present a rare case of a 51-year-old patient with metastatic castration-resistant prostate cancer who complained of...
3.
Dieudonne A, Bailly C, Cachin F, Edet-Sanson A, Kraeber-Bodere F, Hapdey S, et al.
Eur J Nucl Med Mol Imaging
. 2023 Dec;
51(4):947-950.
PMID: 38110711
No abstract available.
4.
Roy M, Edet-Sanson A, Lefebvre H, Vera P, Decazes P
Diagnostics (Basel)
. 2022 Oct;
12(10).
PMID: 36292070
Radio-iodine refractory (RAI-R) differentiated thyroid cancer (DTC) is a rare disease with a poor prognosis and limited therapeutic resources. Therefore, identifying prognostic factors is essential in order to select patients...
5.
Pulcini S, Berghian A, Edet-Sanson A, Carre F, Fontanilles M
Bull Cancer
. 2021 Apr;
108(7-8):779-782.
PMID: 33867122
No abstract available.
6.
Texte E, Gouel P, Thureau S, Lequesne J, Barres B, Edet-Sanson A, et al.
EJNMMI Phys
. 2020 May;
7(1):28.
PMID: 32399752
Purpose: To determine the impact of the Bayesian penalized likelihood (BPL) reconstruction algorithm in comparison to OSEM on hypoxia PET/CT images of NSCLC using F-MIZO and F-FAZA. Materials And Methods:...
7.
Hapdey S, DuBray B, Chastan M, Thureau S, Gouel P, Edet-Sanson A, et al.
Q J Nucl Med Mol Imaging
. 2020 Jan;
66(2):171-178.
PMID: 31922369
Background: PET-CT with F-FDG or other radiopharmaceuticals is a recommended tool to help the delineation of lung cancers candidate to radiotherapy. The motion artifacts caused by respiratory movements are reduced...
8.
Ciappuccini R, Edet-Sanson A, Saguet-Rysanek V, Gauthe M, Bardet S
Clin Nucl Med
. 2019 Jul;
44(8):663-665.
PMID: 31274618
A 66-year-old man with prostate cancer underwent F-fluorocholine PET/CT and thereafter Ga-labeled prostate-specific membrane antigen PET/CT to explore a rising prostate-specific antigen level. Both PET/CT studies showed a thyroid incidentaloma...
9.
Xie T, Zanotti-Fregonara P, Edet-Sanson A, Zaidi H
J Nucl Med
. 2018 Jan;
59(9):1451-1458.
PMID: 29371408
The radiation dose delivered to pregnant patients during radiologic imaging procedures raises health concerns because the developing embryo and fetus are considered to be highly radiosensitive. To appropriately weigh the...
10.
Vera P, Edet-Sanson A, Quieffin F, Le Cloirec J, Bertrand A, Cailleaux M, et al.
Q J Nucl Med Mol Imaging
. 2017 May;
63(3):311-320.
PMID: 28478664
Background: Management of patients with well-differentiated thyroid carcinoma (WDTC) and positive thyroglobulin (Tg)/negative iodine-131 whole body scintigraphy (WBS) remains challenging. Here, we investigate the specific role of diffusion-weighted magnetic resonance...